| This week's sponsor is CMIC Group. | |  | Partner with Japan’s Largest CRO for your global drug development
CMIC is the largest CRO in Japan, with extended services in drug development and GMP manufacturing, site management, regulatory consulting and contract sales. We have the full end to end solution to help you enter Japan market and fulfill your drug development and manufacturing needs in US, Japan and Asia. To learn more, click here. |
Today's Rundown Featured Story | | | Sunday, July 15, 2018 Urovant filed to raise $150 million in its IPO, which will push the company's lead asset through the clinic in a pair of indications. |
|
|
Top Stories Monday, July 16, 2018 We’re looking for women in biotech, pharma and medtech who stand out as leaders, innovators and mentors in organizations big and small. Monday, July 16, 2018 Sangamo's SVP and Chief Technology Officer Michael Holmes is resigning to join an unnamed biotech startup. His departure comes just two months after Curt Herberts, then Sangamo's chief business officer, left to lead business development at Senti Biosciences. Monday, July 16, 2018 GlaxoSmithKline is close to ending a six-decade drought in relapse-preventing therapies for Plasmodium vivax—one of the most common forms of malaria. Monday, July 16, 2018 California startup Pliant Therapeutics has raised a healthy $62 million series B to help fund its proof of concept tests across a range of scarring diseases. Monday, July 16, 2018 It’s an interesting trip, reading the comprehensive account of Theranos’ rise and fall, and that of its founder, Elizabeth Holmes—especially when taken as a careful watcher of the biotech industry or simply knowing the tale’s ending, such as it is. Monday, July 16, 2018 Neuroscience drug discoverer Verge Genomics has raised $32 million in early venture capital financing, a large boost to its plans to bring its AI-generated compounds to the clinic against amyotrophic lateral sclerosis and Parkinson’s disease within the next three years. | This week's sponsor is ExL Events. | |  | |
Resources Sponsored by: Veeva See results from the Tufts eClinical Landscape Study – CRO Report on current data management practices, goals, and challenges for contract research organizations (CROs). Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. Sponsored by: Patheon, part of Thermo Fisher Scientific Biologics, orphan drugs, and precision medicine are on the rise, and that means some big changes for drug development and manufacturing companies. What should pharma companies look for when navigating this new era of small-volume manufacturing? Here are some ideas to consider when developing a new manufacturing strategy. |
|
